Cargando…
Oesophageal cancer: assessment of response and follow up
The prognosis for oesophageal cancer is poor with a median survival of 3–5 months and recurrences are frequent. The best chance of cure is successful surgery and pre-operative chemoradiotherapy is used to try and improve outcomes. However, patients may either not respond or may progress during thera...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
e-Med
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727976/ https://www.ncbi.nlm.nih.gov/pubmed/17921096 http://dx.doi.org/10.1102/1470-7330.2007.9019 |
| _version_ | 1782170717773627392 |
|---|---|
| author | Rankin, S.C. |
| author_facet | Rankin, S.C. |
| author_sort | Rankin, S.C. |
| collection | PubMed |
| description | The prognosis for oesophageal cancer is poor with a median survival of 3–5 months and recurrences are frequent. The best chance of cure is successful surgery and pre-operative chemoradiotherapy is used to try and improve outcomes. However, patients may either not respond or may progress during therapy and it is important to differentiate the responders from non-responders. Clinical parameters such as weight gain and improvement in swallowing can be assessed but imaging is used in an attempt to improve outcomes. |
| format | Text |
| id | pubmed-2727976 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | e-Med |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27279762009-10-01 Oesophageal cancer: assessment of response and follow up Rankin, S.C. Cancer Imaging Article The prognosis for oesophageal cancer is poor with a median survival of 3–5 months and recurrences are frequent. The best chance of cure is successful surgery and pre-operative chemoradiotherapy is used to try and improve outcomes. However, patients may either not respond or may progress during therapy and it is important to differentiate the responders from non-responders. Clinical parameters such as weight gain and improvement in swallowing can be assessed but imaging is used in an attempt to improve outcomes. e-Med 2007-10-01 /pmc/articles/PMC2727976/ /pubmed/17921096 http://dx.doi.org/10.1102/1470-7330.2007.9019 Text en © 2007 International Cancer Imaging Society |
| spellingShingle | Article Rankin, S.C. Oesophageal cancer: assessment of response and follow up |
| title | Oesophageal cancer: assessment of response and follow up |
| title_full | Oesophageal cancer: assessment of response and follow up |
| title_fullStr | Oesophageal cancer: assessment of response and follow up |
| title_full_unstemmed | Oesophageal cancer: assessment of response and follow up |
| title_short | Oesophageal cancer: assessment of response and follow up |
| title_sort | oesophageal cancer: assessment of response and follow up |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727976/ https://www.ncbi.nlm.nih.gov/pubmed/17921096 http://dx.doi.org/10.1102/1470-7330.2007.9019 |
| work_keys_str_mv | AT rankinsc oesophagealcancerassessmentofresponseandfollowup |